Skip to main content

Global Tamoxifen Market to Reach Worth USD 683.7 Mn by 2022: Emerging Countries to Witness Higher Demand

According to the latest report published by Credence Research, Inc. “Tamoxifen Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the tamoxifen market was valued at USD 675.7 Mn in 2015, and is expected to reach USD 683.6 Mn by 2022, expanding at a CAGR of 0.07% from 2016 to 2022.
Browse the full report Tamoxifen: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at http://www.credenceresearch.com/report/tamoxifen-market
Market Insights
Tamoxifen is the oldest and among the most prescribed selective estrogen receptor modulator for breast cancer treatment and management. Tamoxifen is approved for early stage, hormone receptor positive breast cancer in men and women, after surgery or chemotherapy to reduce recurrence risk, and for management of advanced stage or metastatic hormone-receptor positive breast cancer. Women at high risk of developing breast cancer also use Tamoxifen. Tamoxifen is at the maturity stage of product life cycle and is anticipated to experience decline in market growth in the light of introduction of advanced breast cancer management drugs.
This report analyzes the geographical distribution of tamoxifen market in North America, Europe, Asia-Pacific and Rest of the World markets. Currently, North America is the largest market for tamoxifen drugs and it is anticipated that the lead of this region will continue through 2022. Large pool of breast cancer patients, high awareness for breast cancer screening and prevention, well-structured reimbursement scenario and large pool of breast cancer patients. Asia-Pacific and Rest of the World markets will experience the fastest CAGR during 2016-2022. Improving awareness in Middle East and Africa, high incidence of late stage breast cancer in these regions and rapid development of healthcare infrastructure are the prime drivers of Rest of the World market.
Proven long-term efficiency of hormone therapy for management and control of breast cancer across various stages of treatment, in geriatric patients that cannot opt for surgery, and late-stage and recurrent breast cancer, and widespread use of tamoxifen as adjuvant therapy are the prime factors driving the demand for tamoxifen. Growth of tamoxifen-resistant cancer and growing awareness about the drug inducing endometrial cancer may restrain the market growth. Growing application of tamoxifen in treatment of conditions such as McCune-Albright syndrome, infertility, gynecomastia, bipolar disorder, angiogenesis and Riedel’s thyroiditis, and its use in research studies involving gene expression serve as future avenues for the growth of this market.
The global tamoxifen market is moderately competitive with AstraZaneca, Teva Pharmaceutical Industries, Allergan, Mylan, Apotex and Midatech the known players. Anticipated merger of Teva with Allergan is expected to bring a shift in market competition.
ToC
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
Chapter 3 Tamoxifen: Market Dynamics and Outlook
3.1 Introduction
3.2 Breast Cancer: Key Statistics
3.3 Major Events Assessment
3.4 Market Dynamics
3.4.1 Drivers
3.4.1.1 Advantages of Hormone Therapy Across Different Stages of Treatment
3.4.1.2 Widespread use as Adjuvant and Neo-Adjuvant Therapy
3.4.2 Challenges
3.4.2.1 Growth in Tamoxifen-Resistant Breast Cancer
3.4.3 Opportunities
3.4.3.1 Alternative uses of Tamoxifen
3.5 Attractive Investment Proposition................
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290
 

Comments

Popular posts from this blog

Electronic Access Control Market By End-Use - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2024

According to a new market research report published by Credence Research “Electronic Access Control Market (By System Component – Hardware: Electronic Locks, Readers, Access Cards, Control Panels, Access Control Servers; Access Control Management Software; Services: Implementation, Integration and Maintenance Services, and ACaaS) - Growth, Future Prospects, Competitive Analysis and Forecast 2016 - 2024”, the global electronic access control market stood at US$ 4,673.1 Mn in 2015 and is estimated to expand with a CAGR of 9.3% from 2016 to 2024. The complete report is available at http://www.credenceresearch.com/report/electronic-access-control-market Market Insights The electronic access control market has been majorly driven by increasing need to achieve enhanced physical and data security at various residential, commercial, industrial and government and defense facilities. With increasing vulnerabilities in data security and rising need to secure data centers, electronic access contro…

Global Wearable Medical Devices Market is Expected to Reach US$ 22,754.6 Mn by 2025: Credence Research

The latest market report published by Credence Research, Inc. “Wearable Medical Devices Market - Growth, Future Prospects, Competitive Analysis, 2017 - 2025,” the global wearable medical devices market was valued at US$ 4,400.7 Mn in 2016, and is expected to reach US$ 22,754.6 Mn by 2025 expanding at a CAGR of 17.09 % from 2017 to 2025. Browse the full report Wearable Medical Devices Market - Growth, Future Prospects, Competitive Analysis, 2017 – 2025 report athttp://www.credenceresearch.com/report/wearable-medical-devices-market Market Insights: According to the World Health Organization report, in 2012, non-communicable diseases were responsible for death of 38 million people, which is 68% of the world’s 56 million deaths. Approximately 16 million deaths were under 70 years of age, these premature deaths are preventable if there is rising public health awareness, inclination for physical activity and preference for more healthy diet. The technocommerical industry has addressed to thi…

Global Aerospace Composites Market Is Expected To Reach US$ 36.20 Bn By 2025: Credence Research

The latest market report published by Credence Research, Inc. “Aerospace Composites Market, By Fiber Type (Carbon Fiber, Glass Fiber, Aramid, and Others), By Application (Interior and Exterior Application), By Resin type (Epoxy, Phenolic, Polyester, Polyamide, and Thermoplastics) and By Region (North America, Europe, Asia Pacific, Latin America, & Middle East & Africa) - Growth, Future Prospects and Competitive Analysis, 2017 - 2025,” the global aerospace composites market was valued at US$ 18.5 Bn in 2016, and is expected to reach US$ 36.20 Bn by 2025, expanding at a CAGR of 8.5% from 2017 to 2025. Browse the full Aerospace Composites Market - Growth, Future Prospects and Competitive Analysis, 2017 – 2025 report at http://www.credenceresearch.com/report/aerospace-composites-market Market Insights Aerospace industry has now switched to composite from plastics due to their attractive mechanical and chemical properties. Aerospace composites finds its application in commercial &am…